Physician profile
Andrew Jeremy Cooper
NPI 1710188479
$101,955,792.60
in general payments reported to CMS, 2019-2025
21 companies · $2.9M in 2025
The $2.9M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50M · 2020: $5.9M · 2021: $11M · 2022: $6.8M · 2023: $45K · 2024: $25M · 2025: $2.9M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $28M · Consulting Fee: $50K · Travel and Lodging: $1,030 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $28,234,003.08 |
| Consulting Fee | $50,440.00 |
| Travel and Lodging | $1,029.88 |
| Food and Beverage | $840.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $101,510,107.68 | 2019-2025 | |
| Medical Device Business Services, INC. | $442,998.43 | 2019-2025 | Actis, Pinnacle, Attune |
| Depuy Synthes Sales INC. | $1,532.48 | 2019-2023 | Monovisc, Attune |
| Stryker Corporation | $508.41 | 2019-2025 | Iconix, Alphavent |
| Zimmer Biomet Holdings, INC. | $166.20 | 2019-2024 | Mymobility Platform |
| Smith+Nephew, INC. | $160.93 | 2019-2025 | Pico 14 |
| Ferring Pharmaceuticals INC. | $39.44 | 2020-2024 | Euflexxa |
| Mvp Orthopedics INC | $38.24 | 2022 | |
| Medtronic USA, INC. | $29.88 | 2019 | |
| Heron Therapeutics, INC. | $25.35 | 2024 | Zynrelef |
| Acumed LLC | $21.13 | 2025 | Acumed |
| Solventum Corporation | $21.03 | 2025 | V.A.C. Veraflo, V.A.C. Dermatac, Prevena |
| Sonex Health, INC. | $19.47 | 2021 | |
| Horizon Therapeutics Plc | $17.74 | 2019 | |
| Ermi LLC | $17.73 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $17.22 | 2019 | |
| Zyla Life Sciences, INC. | $15.96 | 2020 | |
| Arthrosurface Incorporated | $14.53 | 2019 | |
| Amgen INC. | $14.50 | 2022 | |
| Orthofix Medical, INC. | $14.20 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.